COMMITMENTS AND CONTINGENCIES (Tables)

12 Months Ended

Dec. 31, 2017

Commitments and Contingencies Disclosure [Abstract]

A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the year ended December 31, 2017 and 2016 is as follows (in thousands):



	Contingent Consideration Liabilities Related to Acquisition of Derma Sciences (See Note 4)						Contingent Consideration Liability Related to Acquisition of Confluent Surgical, Inc.					Location in Financial Statements
	Short-term			Long-term			Short-term		Long-term
Balance as of January 1, 2016	$	—		$	—		$	—	$	21,831
Change in fair value	—			—			—		205			Selling, general and administrative
Balance as of December 31, 2016	—			—			—		22,036
Additions from acquisition of Derma Sciences	33,707			3,467			—		—
Transfers from long-term to current portion	2,193			(2,193		)	22,184		(22,184		)
Payments	(31,346		)	—			—		—
Change in fair value	(4,239		)	113			294		148			Selling, general and administrative
Balance as of December 31, 2017	$	315		$	1,387		$	22,478	$	—

Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

A reconciliation of the opening balances to the closing balances of these Level 3 measurements is as follows (in thousands):



	Supply Agreement Liability						Above Market Supply Agreement Liability						Location in Statement of Operations
	Short-term			Long-term			Short-term			Long-term
Balance as of January 1, 2016	$	1,991		$	161		$	—		$	931
Payments	(2,000		)	—			—			(47		)
Transfer from long-term to current potion	161			(161		)	—			—
Loss from increase in fair value	14			—			—			1,083			Selling, general and administrative
Other	—			—			—			681			Goodwill
Balance as of December 31, 2016	166			—			—			2,648
Payments	(166		)	—			(113		)	(415		)
Transfer	—			—			3,273			(3,273		)
Loss from increase in fair value	—			—			(519		)	1,040			Selling, general and administrative
Balance as of December 31, 2017	$	—		$	—		$	2,641		$	—